Steve Porada
Stephen Porada is a co-founder of Verséa Health, the parent company of Verséa Discovery, the creators of mescreen™. His career began as an intern at the National Institute of Health, Bethesda and Fort Detrick, MD studying prions and infectious disease. He then served as a pre-clinical scientist studying compounds in development at Ciba-Geigy, now Novartis. He later gained commercial, sales, marketing and business development experience at Abbott Laboratories and Cytyc Corporation. He then joined as a partner at Aventine Co., a start-up medical communications company where he exited the business in a sale of the company to Tarsus, a publicly traded UK company.